With the Agilent Certified Pre-Owned refurbishment process, you can be confident that the Certified Pre-Owned 1260 Infinity II Bio-Inert HPLC will provide you the same performance as a new instrument.

Put your trust in the LC platform that runs, and runs, and runs. Let the Agilent 1260 Infinity II LC take you to the next level of analytical, instrument and laboratory efficiency with the performance ...

Agilent 1260 Infinity 单元液相色谱系统经久耐用，是针对严格要求的 QA/QC 应用，以及需要高性能、低成本的 HPLC 系统的其它常规应用而设计的。Agilent 1260 Infinity 单元液相色谱系统为 模块式设计，是理想的启动系统，未来可以扩展。其分析能力广泛，**压力达 600 bar ...

1260 Infinity II SFC 系统是简单易用的超临界流体色谱 (SFC) 解决方案。UHPLC 性能范围有助于实现类似液相色谱的灵敏度，该解决方案非常适合用于分析手性及非手性化合物中的低浓度杂质。该系统利用食品级 CO 2 ，与需要较高纯度 CO 2 的系统相比，它能够使运行成本 ...

High performance liquid chromatography (HPLC) is a technique in analytical chemistry used to separate, identify, and quantify each component in a liquid mixture. The Agilent 1260 Infinity Quaternary ...

Elevating lab efficiency with enhanced automation, connectivity, and sustainability capabilities SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today announced the release ...

连续稳定运行的液相色谱平台，值得您的信赖。 Agilent 1260 Infinity II 液相色谱拥有满足您期望的性能，以及稳定性和可靠性，让您的分析、仪器和实验室效率迈上一个新台阶，带给您信心十足的日常分析结果。该仪器十分可靠，将**色谱柱技术与先进备件**结合 ...

High performance liquid chromatography (HPLC) is a technique in analytical chemistry used to separate, identify, and quantify each component in a liquid mixture. The Agilent 1260 Infinity Quaternary ...

Agilent Technologies has introduced InfinityLab - a product family of liquid chromatography instruments, columns and supplies – at Analytica 2016 in Munich. Part of the launch was the Agilent 1260 ...

Elevating lab efficiency with enhanced automation, connectivity, and sustainability capabilities SANTA CLARA, Calif.–(BUSINESS WIRE)–Agilent Technologies Inc. (NYSE: A) today announced the release of ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of three InfinityLab Bio LC systems specifically developed to meet the needs of the biopharma ...